BiondVax Announces Third Quarter 2020 Financial Results & Business Update | News
JERUSALEM, Jan. 28, 2021 /PRNewswire/ -- BiondVax Prescribed drugs Ltd. (Nasdaq: BVXV), a biopharmaceutical firm targeted on growing, manufacturing ...
JERUSALEM, Jan. 28, 2021 /PRNewswire/ -- BiondVax Prescribed drugs Ltd. (Nasdaq: BVXV), a biopharmaceutical firm targeted on growing, manufacturing ...